• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 30-Sep-2022 EOD, Market Closed
SENSEX
57,426.92
1,016.96 (1.80%)
NIFTY
17,094.35
276.25 (1.64%)
    No Companies Visited

Announcements

Exchange:

Date Announcement
28-Sep-2022 Sun Pharmaceuticals Industries has completed the acquisition of f Uractiv™ Portfolio from Fiterman Pharma in Romania on 27 September 2022.
04-Aug-2022 Sun Pharmaceuticals Industries announced that the 30th Annual General Meeting (AGM) of the company will be held on 29 August 2022.
03-Aug-2022 Sun Pharmaceutical Industries announced that its Chairman and member of the Board, Israel Makov, will retire from the company upon the completion of his current term post Sun Pharma's Annual General Meeting on 29 August 2022, after having led the organisation for 10 years. He was appointed a Board member and the Chairman in 2012.
26-Jul-2022 Sun Pharmaceutical Industries announced the signing of addendums to the License and Supply Agreements for WINLEVI (clascoterone) cream 1% expanding the territory to include Japan, Australia, New Zealand, Brazil, Mexico and Russia. In 2021, Sun Pharma and Cassiopea had signed License and Supply Agreements for the United States and Canada markets. Sun Pharma launched WINLEVI in the US market in November 2021. Under the terms of the above referred agreements, Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia. Cosmo will be the exclusive supplier of the product. Cassiopea will receive an upfront payment of US$ 7 million, potential regulatory and sales milestones and customary double digit royalties on net sales.
13-Jul-2022 Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Company on 29 July 2022.
01-Jun-2022 Sun Pharmaceuticals Industries announced that the Board of Directors of the Company at its meeting held on 30 May 2022, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 300%) , subject to the approval of the shareholders.
30-May-2022 The Board of Sun Pharmaceuticals Industries at its meeting held on 30 May 2022 has approved Scheme of Amalgamation for merger of Sun Pharmaceutical Medicare, Green Eco Development Centre, Faststone Mercantile Company, Realstone Multitrade, Skisen Labs, being Wholly-owned subsidiaries of the Company (directly or through another Wholly-owned Subsidiary) with the Company.
27-May-2022 Sun Pharmaceutical Industries announced that one of its subsidiaries, S.C. Terapia S.A., Romania has acquired the Uractiv™ portfolio from Fiterman Pharma in Romania. The Uractiv™ portfolio comprises food supplements including minerals, vitamins and adjuvants; cosmetics and medical devices used for maintaining urinary tract health. Uractiv™ is the No. 1 brand in its category in Romania, trusted by consumers for more than 10 years. The portfolio including 12 SKUs has annualised revenues of approximately US$ 8.7 million. The products cater to both adults and children.
18-May-2022 Sun Pharmaceutical Industries announced that one of its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic Acid, in India for reducing low-density lipoprotein(LDL) cholesterol. The company will launch the drug under the brand name “Brillo®”. Brillo® is a first-in-class drug which has a new mechanism of action compared to the currently available lipid-lowering agents. It is indicated for people who have an inherited genetic disorder that causes high cholesterol levels or established heart disease where cholesterol levels remain high, despite lifestyle changes and the use of maximum tolerated dose of statins.
13-May-2022 Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Company on 30 May 2022.
1 2 

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
9769005430
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 30-Sep-2022
  •  ( 15:47) Indices snap 7-day losing streak, Sensex surges 1,017 pts, Nifty reclaims 17,000  
  •  ( 15:21) Dilip Buildcon emerges as L-1 bidder for Rs 723-cr project  
  •  ( 14:39) Goa Carbon temporarily shuts Goa unit  
  •  ( 14:37) Nifty above 17,100 level, metal stocks advance  
  •  ( 12:54) Heritage Foods board approves 1:1 rights issue  
  •  ( 12:34) Market at day's high; Nifty above 17,000; VIX slides over 6%  
  •  ( 12:06) Zydus Lifesciences arm gets 2 observations from USFDA  
  •  ( 12:03) Motherson Sumi Wiring board approves 2:5 bonus issue  
  •  ( 11:37) Nifty above 16,950 mark, Financial services stocks advance  
  •  ( 11:11) LIC raises stake in Deepak Nitrite  
  •  ( 10:57) Bajaj Electricals bags order worth Rs 332 crore  
  •  ( 10:45) Sensex gains 331 pts, Nifty above 16,900 level, RBI hikes key rates  
  •  ( 10:24) IRCON completes Hajipur-Bachhwara doubling project  
  •  ( 10:10) RBI hikes repo rate by 50 bps to 5.90%  
  •  ( 09:47) Lupin gets USFDA nod on Mirabegron tablets  
  •  ( 09:33) Indices edge lower ahead of RBI policy, breadth positive  
  •  ( 08:53) Asian stocks trading lower  
  •  ( 08:28) Tata Comm launches Private 5G Global CoE in India  
Show News
30 September 2022 00:00
3342.15
(-1.26 %)
733.50
(2.07 %)
7337.55
(3.28 %)
1678.60
(2.63 %)
799.75
(4.49 %)
4333.95
(-0.58 %)
2289.50
(2.27 %)
932.55
(1.07 %)
1422.40
(2.93 %)
2696.85
(-0.18 %)
862.80
(2.22 %)
1186.30
(3.78 %)
1413.10
(1.11 %)
332.00
(-0.32 %)
1821.25
(3.22 %)
1848.70
(1.87 %)
1268.70
(0.96 %)
8823.55
(2.35 %)
19124.60
(0.77 %)
159.75
(0.03 %)
212.15
(1.75 %)
2377.70
(2.25 %)
531.05
(1.74 %)
949.00
(1.96 %)
99.30
(2.53 %)
3004.60
(0.24 %)
1008.20
(-0.23 %)
2606.55
(2.95 %)
6249.85
(1.23 %)
394.30
(0.22 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.